Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that valuations remain high. He advises investors to adopt an active strategy, selecting individual growth-oriented stocks instead of relying on index funds.
Copyright 2024 – Finance News Network
28 Aug 2020 - VRX Silica Limited (ASX:VRX) Managing Director, Bruce Maluish provides an update on the company's silica sand projects, the market for silica sand, and timelines.
02 Oct 2024 - Lithium Universe Limited (ASX:LU7) CEO Alex Hanly discusses the company's prefeasibility study, operational costs and development timeline.
27 Apr 2020 - Kazia Therapeutics (ASX:KZA) CEO & MD, Dr. James Garner talks about its Phase II interim results for its glioblastoma drug candidate paxasilib, its pivotal GBM AGILE Phase II clinical study to commence 2H20 and value drivers as the company moves toward registration.
14 Aug 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager David Grace discuss the FY25 full-year results of Australian Foundation Investment Company (ASX:AFI).
15 Aug 2024 - Forbidden Foods Limited (ASX:FFF) CEO and Managing Director Alex Aleksic provides an introduction to the company, discussing its recent acquisition of Good Oats.
01 Mar 2024 - Shaw and Partners Chief Investment Office Martin Crabb discusses the leading indicators for equity markets, financial conditions and central banks.
01 Mar 2021 - Nutritional Growth Solutions Limited (ASX:NGS) Chairman Brian Leedman talks about the science behind the company's nutritional supplement formulae for children, which are designed to promote height and weight.